Roche, Nicolas
Plaza, Vicente
Backer, Vibeke http://orcid.org/0000-0002-7806-7219
van der Palen, Job
Cerveri, Isa
Gonzalez, Chelo
Safioti, Guilherme http://orcid.org/0000-0002-1254-5994
Scheepstra, Irma
Patino, Oliver
Singh, Dave
Funding for this research was provided by:
Teva Pharmaceuticals
Teva Pharmaceuticals
Article History
Received: 14 January 2019
Accepted: 4 November 2019
First Online: 7 January 2020
Competing interests
: N.R. reports grants and personal fees from Boehringer Ingelheim, and Novartis and personal fees from Teva, GSK, AstraZeneca, Chiesi, Mundipharma, Cipla, Sanofi, Sandoz, 3M, Pfizer, and Zambon outside of the published work. V.B., I.C., J.v.d.P., and C.G. declare no conflicts of interest. D.S. received grants and/or personal fees from AstraZeneca, Apellis, Boehringer Ingelheim, Chiesi, Cipla, Genetech, GlaxoSmithKline, Glenmark, Menarini, Merck, Mundipharma, Novartis, Peptinnovate, Pfizer, Pulmatrix, Skyepharma, Teva, Theravance, and Verona. V.P. in the last three years has received honoraria for speaking at sponsored meetings from Astrazeneca, Chiesi, and Novartis; received help assistance to meeting travel from Astrazeneca, Chiesi, and Novartis; acts as a consultant for ALK, Astrazeneca, Boehringer, MundiPharma, and Sanofi; and has received funding/grant support for research projects from a variety of Government agencies and not-for-profit foundations, as well as AstraZeneca, Chiesi, and Menarini. G.S. and O.P. are employees of Teva Pharmaceuticals. I.S. was an employee of Teva Pharmaceuticals at the time the study was conducted.